Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer

Carcinoma of the Corpus Uteri

WT CREASMAN, Franco Odicino, Patrick Maisonneuve et al. · International Journal of Gynecology & Obstetrics · 2006 · 976 citations

Tumoral Pathology, Medicine, Surgical Pathology +7

Principles and Practice of Gynecologic Oncology

William F. Moore · International Journal of Gynecological Pathology · 1997 · 844 citations

Gynecologic Surgery, Medicine, Cancer Management +4

Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis

Yukiharu Todo, Hidenori Kato, Masanori Kaneuchi et al. · The Lancet · 2010 · 764 citations

Surgical Oncology, Gynecological Surgery, Medicine +6

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Gini F. Fleming, Virginia L. Brunetto, David Cella et al. · Journal of Clinical Oncology · 2004 · 561 citations · Full text

PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

John I. Risinger, Kelly S. Hayes, G. Larry Maxwell et al. · PubMed · 1998 · 284 citations

Medicine, Pten Mutation, Pathology +12